AI clinical scribe to cut physician charting time and review burden

AI clinical scribe to cut physician charting time and review burden targets a $6.0B = 5,000 hospitals/integrated health systems x $120,000 ACV (enterprise license + deployment + per-clinician fees per year) total addressable market with medium saturation and a year-over-year growth rate of 25% annual growth for AI clinical documentation adoption in developed health systems.

Key trends driving demand: AI speech and LLM improvements -- higher transcript accuracy reduces time spent on corrections and enables practical scribing pilots; Hospital trials and safety studies -- pilots like the South Australia womens and childrens trial make hospital procurement teams willing to evaluate solutions with clinical validation data; EHR interoperability standards -- wider FHIR and API support lowers integration cost and speeds deployments; Clinician workforce shortages and burnout -- increases willingness to invest in tools that demonstrably reduce documentation time.